Simultaneous determination of Erythromycin ethylsuccinate (cas 1264-62-6) and its metabolite erythromycin in human plasma using liquid chromatography–electrospray ionization mass spectrometry for clinical study

Add time:08/12/2019    Source:sciencedirect.com

A sensitive and selective liquid chromatography–electrospray ionization mass spectrometry (LC–ESI-MS) method was developed for simultaneous identification and quantification of Erythromycin ethylsuccinate (cas 1264-62-6) and erythromycin in human plasma, which can be well applied to clinical study. The method was based on liquid–liquid extraction, followed by a LC procedure with an ODS C18 column, and mixture of acetonitrile and 1.67 mmol/l acetic acid as mobile phase. MS detection was performed using a single quadrupole mass spectrometer in positive selected ion monitoring (SIM) mode. The method was validated to be linear, precise and accurate. The lower limit of quantification of erythromycin ethylsuccinate and erythromycin were both 0.5 ng/ml. The proposed method enables the unambiguous identification and quantification of erythromycin ethylsuccinate and erythromycin for clinical drug monitoring.

We also recommend Trading Suppliers and Manufacturers of Erythromycin ethylsuccinate (cas 1264-62-6). Pls Click Website Link as below: cas 1264-62-6 suppliers

Prev:Voltammetric behavior of Erythromycin ethylsuccinate (cas 1264-62-6) at a renewable silver-amalgam film electrode and its determination in urine and in a pharmaceutical preparation
Next:Construction of universal quantitative models for determination of roxithromycin and Erythromycin ethylsuccinate (cas 1264-62-6) in tablets from different manufacturers using near infrared reflectance spectroscopy)